Variations in the activity of urinary inhibitors in calcium oxalate urolithiasis.
Opinions vary on the effects produced by urinary inhibitors of crystallisation. We describe a simple method for studying inhibitory effects in urine based on nephelometry and optical microscopy. It was concluded that the inhibitory effect of a given substance on calcium oxalate crystallisation depends on the particular sample of urine being examined and that the most effective inhibitor can be determined only by studying the urine of each patient individually.
Grases
F
F
Department of Chemistry, University of the Balearic Islands, Palma de Mallorca, Spain.
Genestar
C
C
March
P
P
Conte
A
A
D002129:Calcium Oxalate / Q000032:analysis; D002807:Chondroitin / Q000031:analogs & derivatives*; D002809:Chondroitin Sulfates / Q000627:therapeutic use*; D002951:Citrates / Q000627:therapeutic use*; D003460:Crystallization; D011756:Diphosphates / Q000627:therapeutic use*; D006801:Humans; D008274:Magnesium / Q000627:therapeutic use*; D009391:Nephelometry and Turbidimetry; D014545:Urinary Calculi / Q000032:analysis / Q000188:drug therapy*
D002951:Citrates; D011756:Diphosphates; D002129:Calcium Oxalate; D002807:Chondroitin; D002809:Chondroitin Sulfates; D008274:Magnesium